COCRYSTAL PHARMA, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
COCRYSTAL PHARMA, INC. (COCP) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$7.87 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-31
- COCRYSTAL PHARMA, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2016-09-30 was -$1.88M.
- COCRYSTAL PHARMA, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2016-06-30 was -$3.23M.
- COCRYSTAL PHARMA, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2015-09-30 was -$508.00K.
- COCRYSTAL PHARMA, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2015-06-30 was -$2.57M, a 154.36% decline year-over-year.
- COCRYSTAL PHARMA, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$7.87M.
- COCRYSTAL PHARMA, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$15.90M.
- COCRYSTAL PHARMA, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2011 was -$5.52M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 9 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$7.87M 10-K · filed 2026-03-31 | |||
| 2024-12-31 | -$15.90M 10-K · filed 2026-03-31 | |||
| 2016-09-30 | -$1.88M 10-Q · filed 2016-11-09 | -$5.11M derived: sum of 2 quarters · filed 2016-11-09 | -$9.12M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$3.23M 10-Q · filed 2016-08-09 | -$7.24M 10-Q · filed 2016-08-09 | ||
| 2015-09-30 | -$508.00K 10-Q · filed 2016-11-09 | -$3.08M derived: sum of 2 quarters · filed 2016-11-09 | -$19.62M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$2.57M 10-Q · filed 2016-08-09 | -$19.11M 10-Q · filed 2016-08-09 | ||
| 2014-09-30 | -$2.55M 10-Q · filed 2015-11-16 | $2.18M derived: sum of 2 quarters · filed 2015-11-16 | $1.81M 10-Q · filed 2015-11-16 | |
| 2014-06-30 | $4.73M 10-Q · filed 2015-08-14 | $4.36M 10-Q · filed 2015-08-14 | ||
| 2011-12-31 | -$5.52M 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |